LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 249

Search options

  1. Article ; Online: Reply to Takeshi Takahashi's Letter to the Editor re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?

    Van Poppel, Hendrik / Roobol, Monique J

    European urology

    2021  Volume 81, Issue 1, Page(s) e23–e24

    MeSH term(s) Early Detection of Cancer ; Humans ; Male ; Prostate-Specific Antigen ; Prostatic Neoplasms/diagnosis ; Russia ; Urology
    Chemical Substances Prostate-Specific Antigen (EC 3.4.21.77)
    Language English
    Publishing date 2021-10-29
    Publishing country Switzerland
    Document type Letter ; Comment
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2021.10.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renée Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission. Eur Urol 2021;79:327-9: Early Detection of Prostate Cancer in High-risk Patients with Negative Fusion Biopsy.

    Van Poppel, Hendrik / Hogenhout, Renée / Albers, Peter / van den Bergh, Roderick C N / Barentsz, Jelle O / Roobol, Monique J

    European urology

    2021  Volume 80, Issue 1, Page(s) e28–e29

    MeSH term(s) European Union ; Humans ; Image-Guided Biopsy ; Male ; Prostatic Neoplasms/diagnosis
    Language English
    Publishing date 2021-05-06
    Publishing country Switzerland
    Document type Letter ; Comment
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2021.04.027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Book ; Online ; E-Book: Management of prostate cancer

    Bolla, Michel / Poppel, Hendrik van

    a multidisciplinary approach

    2017  

    Author's details Michel Bolla, Hendrik van Poppel editors
    Keywords Prostatic Neoplasms / diagnosis ; Prostatic Neoplasms / radiotherapy ; Prostatic Neoplasms / therapy ; Prostatectomy
    Language English
    Size 1 Online-Ressource (viii, 422 Seiten), Illustrationen, Diagramme
    Edition Second edition
    Publisher Springer
    Publishing place Cham
    Publishing country Switzerland
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT019391714
    ISBN 978-3-319-42769-0 ; 9783319427683 ; 3-319-42769-5 ; 3319427687
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  4. Article ; Online: Prostate Cancer Screening at its Best: The Swedish Organized Prostate Cancer Testing Program.

    Albers, Peter / van Poppel, Hendrik

    European urology

    2023  Volume 85, Issue 3, Page(s) 215–216

    MeSH term(s) Male ; Humans ; Prostatic Neoplasms/diagnosis ; Prostate-Specific Antigen ; Early Detection of Cancer ; Sweden/epidemiology ; Mass Screening
    Chemical Substances Prostate-Specific Antigen (EC 3.4.21.77)
    Language English
    Publishing date 2023-12-15
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2023.11.026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The Future of Medical Devices in Europe Is at Stake: Concerns over the Implementation of the Medical Devices Regulation 2017/745.

    Albisinni, Simone / Rassweiler, Jens / van Poppel, Hendrik

    European urology

    2023  Volume 83, Issue 3, Page(s) 191–192

    Abstract: In May 2024, all medical devices in Europe will require to comply with the new Medical Device Regulation 2017/745, including those we have been using for years. Currently, there are major delays and problems associated with this new certification. As ... ...

    Abstract In May 2024, all medical devices in Europe will require to comply with the new Medical Device Regulation 2017/745, including those we have been using for years. Currently, there are major delays and problems associated with this new certification. As clinicians, we express our serious concerns regarding whether the system will be ready on time to ensure that all the medical devices that we use will be available for patient care.
    MeSH term(s) Humans ; Medical Device Legislation ; Europe
    Language English
    Publishing date 2023-01-04
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2022.12.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U.

    Van Poppel, Hendrik / Roobol, Monique J / Chandran, Arunah

    European urology

    2023  Volume 84, Issue 6, Page(s) 519–522

    Abstract: The European Association of Urology, together with consortium partners, has launched PRAISE-U (Prostate Cancer Awareness and Initiative for Screening in the European Union), a project involving 25 institutions across 12 countries that is funded under the ...

    Abstract The European Association of Urology, together with consortium partners, has launched PRAISE-U (Prostate Cancer Awareness and Initiative for Screening in the European Union), a project involving 25 institutions across 12 countries that is funded under the EU4Health program. The aim is to reduce the morbidity and mortality of prostate cancer in EU member states via customized and risk-based screening programs.
    MeSH term(s) Male ; Humans ; European Union ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/therapy ; Early Detection of Cancer ; Europe
    Language English
    Publishing date 2023-09-12
    Publishing country Switzerland
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2023.08.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Men and cancer: Tackling the excess burden.

    Baker, Peter / Aapro, Matti / Collen, Sarah / Price, Richard / van Poppel, Hendrik

    Journal of cancer policy

    2023  Volume 37, Page(s) 100432

    MeSH term(s) Male ; Humans ; Neoplasms/diagnosis ; Body Mass Index
    Language English
    Publishing date 2023-07-19
    Publishing country England
    Document type Editorial
    ISSN 2213-5383
    ISSN (online) 2213-5383
    DOI 10.1016/j.jcpo.2023.100432
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Diagnosing prostate cancer at a curable stage means providing PSA tests to asymptomatic patients.

    Booth, Christopher M / Chinegwundoh, Frank / Allen, Stephen / Van Poppel, Hendrik

    BMJ (Clinical research ed.)

    2022  Volume 378, Page(s) o1714

    MeSH term(s) Humans ; Immunologic Tests ; Male ; Prostate-Specific Antigen ; Prostatic Neoplasms/diagnosis
    Chemical Substances Prostate-Specific Antigen (EC 3.4.21.77)
    Language English
    Publishing date 2022-07-12
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 1362901-3
    ISSN 1756-1833 ; 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    ISSN (online) 1756-1833
    ISSN 0959-8154 ; 0959-8146 ; 0959-8138 ; 0959-535X ; 1759-2151
    DOI 10.1136/bmj.o1714
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Words of wisdom. Re: The role of surgery in high-risk localized prostate cancer.

    Van Poppel, Hendrik

    European urology

    2014  Volume 66, Issue 2, Page(s) 387–389

    MeSH term(s) Humans ; Male ; Prostatic Neoplasms/surgery
    Language English
    Publishing date 2014-08
    Publishing country Switzerland
    Document type Comment ; Journal Article
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2014.05.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future.

    Van Poppel, Hendrik / Albreht, Tit / Basu, Partha / Hogenhout, Renée / Collen, Sarah / Roobol, Monique

    Nature reviews. Urology

    2022  Volume 19, Issue 9, Page(s) 562–572

    Abstract: In the pre-PSA-detection era, a large proportion of men were diagnosed with metastatic prostate cancer and died of the disease; after the introduction of the serum PSA test, randomized controlled prostate cancer screening trials in the USA and Europe ... ...

    Abstract In the pre-PSA-detection era, a large proportion of men were diagnosed with metastatic prostate cancer and died of the disease; after the introduction of the serum PSA test, randomized controlled prostate cancer screening trials in the USA and Europe were conducted to assess the effect of PSA screening on prostate cancer mortality. Contradictory outcomes of the trials and the accompanying overdiagnosis resulted in recommendations against prostate cancer screening by organizations such as the United States Preventive Services Task Force. These recommendations were followed by a decline in PSA testing and a rise in late-stage diagnosis and prostate cancer mortality. Re-evaluation of the randomized trials, which accounted for contamination, showed that PSA-based screening does indeed reduce prostate cancer mortality; however, the debate about whether to screen or not to screen continues because of the considerable overdiagnosis that occurs using PSA-based screening. Meanwhile, awareness among the population of prostate cancer as a potentially lethal disease stimulates opportunistic screening practices that further increase overdiagnosis without the benefit of mortality reduction. However, in the past decade, new screening tools have been developed that make the classic PSA-only-based screening an outdated strategy. With improved use of PSA, in combination with age, prostate volume and with the application of prostate cancer risk calculators, a risk-adapted strategy enables improved stratification of men with prostate cancer and avoidance of unnecessary diagnostic procedures. This combination used with advanced detection techniques (such as MRI and targeted biopsy), can reduce overdiagnosis. Moreover, new biomarkers are becoming available and will enable further improvements in risk stratification.
    MeSH term(s) Early Detection of Cancer/methods ; Europe ; Humans ; Male ; Mass Screening/methods ; Prostate/pathology ; Prostate-Specific Antigen ; Prostatic Neoplasms/pathology ; Randomized Controlled Trials as Topic
    Chemical Substances Prostate-Specific Antigen (EC 3.4.21.77)
    Language English
    Publishing date 2022-08-16
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2493737-X
    ISSN 1759-4820 ; 1759-4812
    ISSN (online) 1759-4820
    ISSN 1759-4812
    DOI 10.1038/s41585-022-00638-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top